Displaying 1 - 12 of 37
Metabolism, Alcohol & Toxicity

Pathophysiological analysis of MASH: targetting clinical manifestations

Webcasts
View
Metabolism, Alcohol & Toxicity

Novo Nordisk: Addressing MASH as a liver manifestation of the metabolic disease (Complete Session)

Webcasts
View
Metabolism, Alcohol & Toxicity

Approaching MASH as a metabolic disease with the need for holistic therapy

Webcasts
View
Metabolism, Alcohol & Toxicity

Panel Discussion

Webcasts
View
Metabolism, Alcohol & Toxicity

Summary and Closing remarks

Webcasts
View
Metabolism, Alcohol & Toxicity

Novo Nordisk: "Walking the clinical care pathway for NASH: learnings from implementation" (Complete Session)

Webcasts
View
Metabolism, Alcohol & Toxicity

Takeda: "Alpha-1 antitrypsin deficiency (AATD) - Associated liver disease: More common than you may think" (Complete Session)

Webcasts
View
Metabolism, Alcohol & Toxicity

Novo Nordisk and Echosens: "Clinical challenge: Updates on the non-invasive toolbox for NASH and Fibrosis" (Complete Session)

Webcasts
View
Metabolism, Alcohol & Toxicity

Adults with Pi*MZ or Pi*ZZ genotype: Cases review

Webcasts
View
Metabolism, Alcohol & Toxicity

Introduction to AATD and AATD-associated liver disease

Webcasts
View
Metabolism, Alcohol & Toxicity

Diagnosis of AATD-associated liver disease with a review of pediatric cases

Webcasts
View
Metabolism, Alcohol & Toxicity

Unmet needs and future outlook for patients with AATD-associated liver disease

Webcasts
View
Displaying 1 - 12 of 37